ERGi-USU-6 mesylate
Product Specifications
Target
Others
Related Pathways
Others
Bioactivity
ERGi-USU-6 (mesylate) is a new selective ERG-positive prostate cancer inhibitor, with an IC50 of 0.089 μM, and is a salt derivative of ERGi-USU-6.
Molecular Formula
C14H18N4O4S
Molecular Weight
338.38
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog